Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations.
Amano H, Uchida H, Harada K, Narita A, Fumino S, Yamada Y, Kumano S, Abe M, Ishigaki T, Sakairi M, Shirota C, Tainaka T, Sumida W, Yokota K, Makita S, Karakawa S, Mitani Y, Matsumoto S, Tomioka Y, Muramatsu H, Nishio N, Osawa T, Taguri M, Koh K, Tajiri T, Kato M, Matsumoto K, Takahashi Y, Hinoki A.
Amano H, et al. Among authors: nishio n.
Cancer Sci. 2024 Feb 27. doi: 10.1111/cas.16116. Online ahead of print.
Cancer Sci. 2024.
PMID: 38411285
Free article.